TLDR: Marketers already own the scarce half of a brand-tech role — audience judgement. Adding marketing technology, data literacy and regulatory fluency turns that judgement into one of the hardest-to-fill profiles in pharma and MedTech.
Audience judgement is the half of a brand-tech role that employers struggle to train
Hiring managers building commercial teams in regulated industries describe the same shortage from two directions. Technologists who can configure a campaign stack are available. People who can look at a segment of oncology nurses, a compliance constraint and a launch deadline, and decide what the message should actually say, remain considerably rarer. That second capability is the one a working marketer already holds, usually without pricing it correctly, because from the inside it feels like ordinary competence. Audience judgement is a compressed form of pattern recognition: someone who has run campaigns for three or four years has watched hundreds of messages meet an audience and has absorbed which framings earn attention from a specialist and which slide past a general reader. That accumulated feedback loop is what allows a marketer to reject a technically correct piece of copy because it will land badly with a hospital procurement committee.
The reverse journey demonstrates the asymmetry plainly. A data engineer or automation specialist can be taught the mechanics of segmentation quickly, because those mechanics are documented, testable and largely identical from one company to the next. Teaching that same person to sense when a claim reads as promotional to a clinician takes years of exposure to clinicians, since the signal lives in tone, professional convention and the reader’s assumptions about who is speaking. Employers therefore treat creative judgement as the binding constraint and technical skill as the variable they can supply through training, tooling or a vendor. A marketer who understands this stops apologising for a non-technical background and starts negotiating from the scarcer side of the equation, which changes both the roles worth applying for and the salary conversation that follows.
Naming the strength precisely is the first practical step, and it works best written down rather than held loosely in mind. Inventory the audiences you have genuinely learned — specialist physicians, hospital procurement committees, private-bank clients, laboratory directors — along with the specific decisions you influenced and the constraints you worked inside. Precision matters because the inventory doubles as a routing device: a marketer who has spent four years persuading laboratory directors is a candidate for diagnostics and In Vitro Diagnostic Regulation work, while one who has sold to hospital buyers is a candidate for MedTech capital equipment. Each destination implies a different technical layer worth learning and several that can be safely ignored. That inventory becomes the spine of the reskilling plan, and everything that follows attaches to it.
Marketing technology becomes a career asset the moment you build inside the stack rather than brief it
The first layer to add is operational fluency with the systems that carry a campaign from idea to inbox, and the distinction that matters to employers sits between describing what should happen and being able to make it happen inside the platform. Building removes a handoff from the delivery chain and shortens every cycle that follows. Start with the customer relationship management layer, since it holds the record everything else references. In pharma and MedTech commercial teams this usually means a life-sciences CRM such as Veeva or a Salesforce-based equivalent, wrapped in approval workflows that gate what a field representative may show a physician. Learn how a piece of content moves through medical, legal and regulatory review inside that system, how approved claims are locked to an asset, and how consent status travels with a contact record.
Understanding those mechanics changes what you propose, because you can see in advance which ideas will survive review and which will consume a month before dying. Add the delivery and measurement layer next: marketing automation, the content management system, tag and consent management, and whatever analytics environment the company reports from. This cluster repays study because most campaign failures in regulated settings are plumbing failures rather than creative ones. A consent flag configured incorrectly suppresses an entire segment while the dashboard reports low interest. A tracking parameter that never fires makes a strong campaign look weak in the quarterly review, and the budget moves accordingly. Someone who can open the configuration and diagnose the cause holds a different kind of authority in a meeting than someone who can only report the symptom.
Build this through supervised practice rather than passive study, because tooling knowledge acquired without a live problem attached tends to evaporate before an interviewer can test it. Ask for administrator access to a sandbox, rebuild one of your own past campaigns inside it end to end, and document each step where the platform forced a decision you had previously delegated. The friction points are the lesson: the field that refused the value you assumed, the workflow that required an approval you had never seen requested, the export that revealed how the data was actually structured. Vendor certification programmes are worth taking afterwards, once you have enough context for the terminology to mean something and enough scar tissue to know which questions the syllabus quietly avoids.
Data literacy in a regulated team means defending a decision, not running a regression
The second layer causes the most unnecessary anxiety, because marketers assume it demands statistical training. The standard applied in practice is narrower and considerably more useful: frame a commercial question so that data can answer it, read the answer honestly, and defend the resulting decision to a sceptical director. Begin with question design, since it determines everything downstream. “Did the campaign perform?” produces a dashboard nobody acts on. “Which of our three specialist segments requested a follow-up visit after the second touch, and what did the ones who converted have in common?” produces a decision about where to spend the next quarter. The mechanism is straightforward — a question naming an audience, a behaviour and a time window forces the analysis toward a specific column of data, which in turn forces a specific action.
Marketers who practise that framing become useful to commercial leadership almost immediately, and the next discipline is reading a result against its own limitations. Regulated marketing generates small, noisy samples: a target list of four hundred cardiologists produces engagement numbers that swing hard on a handful of individuals, and a single congress week can distort a whole quarter. Knowing when a difference reflects a real pattern and when it reflects three people opening an email twice protects a team from expensive overreaction. The practical skill reduces to three habits — asking what sample sits behind a percentage, what the comparison period looked like, and what else changed at the same time. Those three questions catch most of the errors that reach a leadership slide.
Competence here shows in the calibre of your caveats rather than the confidence of your headline. A candidate who says a channel outperformed by a wide margin sounds assured; a candidate who adds that the effect concentrated in one country, coincided with a congress, and warrants a controlled retest sounds employable. The reason is that a director’s real question is whether your recommendation will survive being acted on, and a caveat is evidence you have already stress-tested it yourself. Data literacy expressed as disciplined scepticism therefore reads as seniority rather than hesitancy. It also pairs naturally with the compliance layer that follows, where the same instinct — asking what evidence a claim rests on — is the entire professional standard.
Regulatory fluency is what converts a capable marketer into a specialist a Swissmedic-facing team will hire
The third layer decides which sector will have you. Every regulated industry runs its commercial function inside a specific legal perimeter, and knowing that perimeter well enough to design compliant work from the first draft is what separates a general marketer from a brand-tech specialist. Map your target sector’s instruments before anything else. A marketer moving toward Swiss and European pharmaceuticals needs working knowledge of Swissmedic requirements and the European Medicines Agency framework governing what may be claimed and to whom. MedTech work sits under the EU Medical Device Regulation and, for diagnostics, the In Vitro Diagnostic Regulation, both of which tie promotional claims to the intended purpose registered in the technical documentation. United States campaigns bring Food and Drug Administration expectations into the same asset, and Swiss financial services work answers to the Swiss Financial Market Supervisory Authority.
Those frameworks shape the brief itself rather than arriving as a late review comment, and the data rules layered on top govern the technology half of the role. European campaigns operate under the General Data Protection Regulation; Swiss operations answer to the revised Federal Act on Data Protection, which carries its own consent and transparency expectations for domestic processing. Where a team applies automated scoring or generative tooling to customer data, the EU AI Act adds further obligation depending on how the system is used. The value of holding all of this at once is timing: a specialist who can say which instrument applies to a proposed tactic, and what evidence review will ask for, becomes the person consulted before the budget is committed rather than after it has been spent.
Acquire this through proximity rather than reading alone, because the published text of a regulation tells you the rule and not how your reviewers interpret it. Ask to observe a medical, legal and regulatory review board. Ask the reviewer who rejected your copy to explain the specific provision behind the objection, and keep a private log of those rulings alongside the wording that eventually passed. Within a few months the log becomes a working model of how your sector thinks — which claims need a reference, which comparisons are unavailable, which patient language is permitted in which market. That model is what you will be asked to demonstrate when the role is on the table, and it is the part of the profile a competitor cannot download.
One shipped project proves the hybrid skill faster than any certificate
Reskilling converts into an offer at the point where it becomes visible and testable. Employers evaluating a hybrid profile want evidence that the three layers operated together on a real problem, under a real constraint, with a result someone else can verify. Claims about capability are cheap in this market precisely because the vocabulary is freely available, so an interviewer’s working method is to ask for the specific instance behind each claim and listen for the detail that could only come from having done it. Preparing that evidence deliberately, layer by layer, earns more than another line of training on the CV.
| Layer | Evidence an interviewer accepts |
|---|---|
| Audience judgement | A framing you rejected, and the audience reasoning behind the rejection |
| Marketing technology | A workflow you configured yourself and can walk through screen by screen |
| Data literacy | A decision you changed on the basis of a result, including what you doubted |
| Regulatory fluency | A named instrument you designed around before review, and how review responded |
Choose a project inside your current job wherever possible, because internal work carries stakes a personal exercise cannot simulate. Take a campaign nobody has modernised, rebuild it with the segmentation you can now defend, configure the delivery yourself, take it through compliance review, and measure it against the previous version. The project earns its value from friction: the reviewer who pushed back, the field team that disagreed with the targeting, the tracking that broke a week in. Those episodes are what an interviewer probes, because they reveal how you behaved once the plan met resistance — which is the only reliable predictor of how you will behave inside their organisation. A certificate cannot supply that, and neither can a case study you controlled from end to end.
Rewrite the CV around the combination once the project exists. A hybrid profile suffers when it appears as a list of tools beside a list of campaigns, because the reader then has to assemble the story themselves and most readers will not. Lead instead with the outcome you directed, then show the layers that produced it, so the technology reads as an instrument rather than a hobby. Structured learning strengthens the strategic half of that story, and Edward Galle candidates can use the HBR-backed training journeys to build the judgement these roles reward. The signal you want the reader to receive is a professional who directed technology toward a commercial result.
Treat the timeline as months rather than years, and treat the market as an ally. The World Economic Forum’s assessment of core skills shifting across occupations describes exactly the churn that makes hybrid profiles scarce, and regulated employers feel that scarcity acutely because their compliance requirements shrink the eligible pool further before a search even begins. Scarcity of this kind has a natural life: it closes as training routes formalise and the profile hardens into a recognised job title with a recognised syllabus. A marketer who starts the first layer this quarter, ships the proof project in the next, and enters the market with a verifiable story arrives while the shortage is still open and the negotiating position still belongs to the candidate.
Edward Galle places brand-tech and commercial talent across pharma, MedTech, life sciences and finance in Switzerland, the EU and the US. Professionals building toward this profile can submit a CV for matching, and employers assembling hybrid commercial teams can review our services for companies or talk to our team.
References
- World Economic Forum. Future of Jobs Report. https://www.weforum.org/publications/the-future-of-jobs-report-2025/
- Edward Galle. Brand-Tech Talent: The Hybrid Skill Set. https://edwardgalle.com/brand-tech-talent-hybrid-skill-set-commercial-teams-pharma-medtech/
